An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)

NCT05223920 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)